In pancreatic cancer, YAP promotes cell motility and invasion via LPA receptor 3 (LPAR3) [136], while in mesothelioma and breast cancer cells, YAP mediates the expression of receptor of hyaluronan-mediated motility (RHAMM). Here, LPAR3 is linked to breast carcinoma.